Pediatric Gastroenterology, Hepatology & Nutrition

  • 제19권2호
  • /
  • Pages.139-142
  • /
  • 2016
  • /
  • 2234-8646(pISSN)
  • /
  • 2234-8840(eISSN)
대한소아소화기영양학회 (The Korean Society of Pediatric Gastroenterology, Hepatology and Nutrition)
권호 표지
DOI QR코드

DOI QR Code

The Challenges of Diagnosing and Following Wilson Disease in the Presence of Proteinuria

  • Khan, Soofia (Department of Pediatrics, Phoenix Children's Hospital) ;
  • Schilsky, Michael (Department of Gastroenterology, Yale University Medical Center) ;
  • Silber, Gary (Department of Pediatrics, Phoenix Children's Hospital) ;
  • Morgenstern, Bruce (Department of Pediatrics, Roseman University of Health Sciences) ;
  • Miloh, Tamir (Department of Pediatrics, Texas Children's Hospital)
  • 투고 : 2015.10.06
  • 심사 : 2016.01.04
  • 발행 : 2016.06.30
PDF 다운로드
⟨ 이전 논문 다음 논문 ⟩

초록

The coexistence of Wilson disease with Alport syndrome has not previously been reported. The diagnosis of Wilson disease and its ongoing monitoring is challenging when associated with an underlying renal disease such as Alport syndrome. Proteinuria can lead to low ceruloplasmin since it is among serum proteins inappropriately filtered by the damaged glomerulus, and can also lead to increased urinary loss of heavy metals such as zinc and copper. Elevated transaminases may be attributed to dyslipidemia or drug induced hepatotoxicity. The accurate diagnosis of Wilson disease is essential for targeted therapy and improved prognosis. We describe a patient with a diagnosis of Alport syndrome who has had chronic elevation of transaminases eventually diagnosed with Wilson disease based on liver histology and genetics.

키워드

참고문헌

  1. Savige J, Gregory M, Gross O, Kashtan C, Ding J, Flinter F. Expert guidelines for the management of Alport syndrome and thin basement membrane nephropathy. J Am Soc Nephrol 2013;24:364-75. https://doi.org/10.1681/ASN.2012020148
  2. Roberts EA, Schilsky ML; American Association for Study of Liver Diseases (AASLD). Diagnosis and treatment of Wilson disease: an update. Hepatology 2008; 47:2089-111. https://doi.org/10.1002/hep.22261
  3. European Association for Study of Liver. EASL clinical practice guidelines: Wilson's disease. J Hepatol 2012; 56:671-85. https://doi.org/10.1016/j.jhep.2011.11.007
  4. Morgan SM, Zantek ND. Therapeutic plasma exchange for fulminant hepatic failure secondary to Wilson's disease. J Clin Apher 2012;27:282-6. https://doi.org/10.1002/jca.21239
  5. Asfaha S, Almansori M, Qarni U, Gutfreund KS. Plasmapheresis for hemolytic crisis and impending acute liver failure in Wilson disease. J Clin Apher 2007;22:295-8. https://doi.org/10.1002/jca.20140
  6. da Silva GH, Alves AV, Duques P, Seva-Pereira T, Soares EC, Escanhoela CA. Acute hepatotoxicity caused by enalapril: a case report. J Gastrointestin Liver Dis 2010;19:187-90.
  7. Droste HT, de Vries RA. Chronic hepatitis caused by lisinopril. Neth J Med 1995;46:95-8. https://doi.org/10.1016/0300-2977(94)00058-H
  8. Schattner A, Kozak N, Friedman J. Captopril-induced jaundice: report of 2 cases and a review of 13 additional reports in the literature. Am J Med Sci 2001;322: 236-40. https://doi.org/10.1097/00000441-200110000-00016
  9. Teslariu O, Nechifor M. Divalent cations levels change in nephrotic syndrome. Rev Med Chir Soc Med Nat Iasi 2012;116:883-7.
  10. Stec J, Podracka L, Pavkovcekova O, Kollar J. Zinc and copper metabolism in nephrotic syndrome. Nephron 1990;56:186-7. https://doi.org/10.1159/000186130
  11. Bovio G, Piazza V, Ronchi A, Montagna G, Semeraro L, Galli F, et al. Trace element levels in adult patients with proteinuria. Minerva Gastroenterol Dietol 2007;53: 329-36.